| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1097/MCP.0B013E3282F10A16 |
| P698 | PubMed publication ID | 17901760 |
| P2093 | author name string | Carla Colombo | |
| P433 | issue | 6 | |
| P921 | main subject | cystic fibrosis | Q178194 |
| liver disease | Q929737 | ||
| P304 | page(s) | 529-536 | |
| P577 | publication date | 2007-11-01 | |
| P1433 | published in | Current Opinion in Pulmonary Medicine | Q23930051 |
| P1476 | title | Liver disease in cystic fibrosis | |
| P478 | volume | 13 |
| Q37800159 | A review of abdominal organ transplantation in cystic fibrosis |
| Q33470424 | Abdominal symptoms in cystic fibrosis and their relation to genotype, history, clinical and laboratory findings |
| Q36499679 | Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets |
| Q50717522 | Adult-onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entity. |
| Q40792557 | Amniotic mesenchymal stem cells: a new source for hepatocyte-like cells and induction of CFTR expression by coculture with cystic fibrosis airway epithelial cells |
| Q35926418 | Approach to a patient with elevated serum alkaline phosphatase |
| Q83744474 | Ascites and variceal bleeding occurring in a 20-year-old with cystic fibrosis |
| Q92061692 | Assessment of Selected Parameters of Liver Fibrosis and Inflammation in Patients with Diagnosed Cystic Fibrosis |
| Q24200401 | Bisphosphonates for osteoporosis in people with cystic fibrosis |
| Q24239980 | Bisphosphonates for osteoporosis in people with cystic fibrosis |
| Q43538692 | Brazilian guidelines for the diagnosis and treatment of cystic fibrosis. |
| Q38996435 | Can Cystic Fibrosis Patients Finally Catch a Breath With Lumacaftor/Ivacaftor? |
| Q36621970 | Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation |
| Q30278529 | Choline Supplementation With a Structured Lipid in Children With Cystic Fibrosis: A Randomized Placebo-Controlled Trial |
| Q28660820 | Cirrhosis and other liver disease in cystic fibrosis |
| Q50916795 | Control of oxygen tension recapitulates zone-specific functions in human liver microphysiology systems. |
| Q51527949 | Dental treatment for people with cystic fibrosis. |
| Q53627194 | Gastrointestinal Manifestations of Cystic Fibrosis. |
| Q30418279 | Genetic modifiers of liver disease in cystic fibrosis |
| Q92855722 | Hepatic Manifestations of Cystic Fibrosis |
| Q64897087 | Hepatic fibrosis scores and serum biomarkers in pediatric hepatology. |
| Q30477154 | Hepatobiliary and pancreatic imaging in children—techniques and an overview of non-neoplastic disease entities |
| Q35058280 | Intestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosis |
| Q92841151 | Lumacaftor/ivacaftor therapy is associated with reduced hepatic steatosis in cystic fibrosis patients |
| Q35644328 | Metal Zn(II), Cu(II), Ni (II) complexes of ursodeoxycholic acid as putative anticancer agents |
| Q90266684 | MicroRNA Sequencing Identifies a Serum MicroRNA Panel, Which Combined With Aspartate Aminotransferase to Platelet Ratio Index Can Detect and Monitor Liver Disease in Pediatric Cystic Fibrosis |
| Q92006711 | Microgallbladder: Self-Remitting Acute Cholecystitis-Like Condition Unique to Patients with Cystic Fibrosis |
| Q37887172 | Mouse models of cystic fibrosis: phenotypic analysis and research applications |
| Q92267356 | Multidisciplinary Care for Cystic Fibrosis Liver Disease: Where Does the Adult Hepatologist Fit In? |
| Q33682175 | Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis |
| Q88873934 | Neutrophils as a Potential Source of Chitinase-3-like Protein 1 in Cystic Fibrosis |
| Q30401743 | Noninvasive methods, including transient elastography, for the detection of liver disease in adults with cystic fibrosis |
| Q84800550 | Outcome in Cystic Fibrosis Liver Disease |
| Q36312709 | Pancreatic and biliary secretion are both altered in cystic fibrosis pigs. |
| Q26825799 | Pathophysiology of cystic fibrosis and drugs used in associated digestive tract diseases |
| Q38932077 | Pluripotent stem cells for disease modeling and drug screening: new perspectives for treatment of cystic fibrosis? |
| Q37373924 | Regulation of hepatic sulfotransferase (SULT) 1E1 expression and effects on estrogenic activity in cystic fibrosis (CF). |
| Q47132564 | Relation of Ultrasound Findings and Abdominal Symptoms obtained with the CFAbd-Score in Cystic Fibrosis Patients |
| Q49334378 | Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease |
| Q42326059 | Specific bile acids inhibit hepatic fatty acid uptake in mice |
| Q43203725 | Stimulation of nuclear receptor peroxisome proliferator-activated receptor-γ limits NF-κB-dependent inflammation in mouse cystic fibrosis biliary epithelium. |
| Q63247975 | Strategies for management of pediatric cystic fibrosis liver disease |
| Q37521970 | The immunopathology of human biliary cell epithelium |
| Q38789869 | The intestinal microbiome and paediatric liver disease |
| Q91914943 | The road for survival improvement of cystic fibrosis patients in Arab countries |
| Q91789114 | Transient Elastography in the Evaluation of Cystic Fibrosis-Associated Liver Disease: Systematic Review and Meta-analysis |
Search more.